Gilead Sciences is a large biopharmaceutical company that discovers, develops, and sells medicines for hard-to-treat diseases. The filings show it paid the Tiber Creek Group (and hired B Hall Strategies) to lobby on health issues such as drug pricing, pharmacy matters, and Medicare/Medicaid, with a focus on HIV medications. This lobbying aims to influence policies that affect access, coverage, and pricing of its drugs.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
mr JAMES BRYANT HALL ii
The latest disclosures for this client.
B HALL STRATEGIES, LLC
Q2B HALL STRATEGIES, LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
B HALL STRATEGIES, LLC
B HALL STRATEGIES, LLC
Q4B HALL STRATEGIES, LLC
Q3B HALL STRATEGIES, LLC
Q2B HALL STRATEGIES, LLC
RR